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Veto cell-mediated suppression of cytotoxic T lymphocyte (CTL) responses has been proposed 
as one mechanism by which self-tolerance is maintained in mature T cell populations.  We have 
previously reported that murine bone marrow ceils cultured in the presence of high-dose interleukin 
2 (1I:2) (activated bone marrow cells [ABM]) mediate strong veto suppressor function. To examine 
mechanisms by which ABM may suppress precursor CTL (p-CTL) responses, we used p-CTL 
generated from spleen cells of transgenic mice expressing a T cell receptor specific for H-2 L  d. 
It was demonstrated that the cytotoxic response by these p-CTL after stimulation with irradiated 
H-2  a/k spleen cells was suppressed by DBA/2 (H-2  d) ABM, but not by B10.BR (H-2 k) ABM 
or dml (D  d, L  d mutant) ABM. Flow cytometry analysis with propidium iodide staining revealed 
that these p-CTL were specifically deleted by incubation with H-2  d ABM, but not with H-2  k 
ABM. These data indicate that ABM veto cells kill p-CTL with specificity for antigens expressed 
on the surface of the ABM, and that the mechanism for veto cell activity of ABM is clonal 
deletion of p-CTL. 
T 
he mechanisms by which T  lymphocytes develop and 
maintain tolerance to normal self-antigens include the 
clonal deletion of thymocytes expressing autoreactive TCRs 
(1-4) and the induction of antigen unresponsiveness,  or anergy, 
of postthymic T  cells (5-7).  Clonal  elimination of T  cells 
that have exited the thymus is less dearly established  as a general 
mechanism of tolerance (8-10). Studies on the generation of 
cytotoxic CTL response have shown that these responses can 
be specifically suppressed by veto cells, and this suppression 
has been proposed as one mechanism by which self-tolerance 
is maintained in mature T cell populations (11-14). Whether 
veto cells exert their effect by the induction of clonal anergy 
or clonal deletion of precursor CTL (p-CTL)  1 has not been 
clearly determined previously. 
We have reported that murine bone marrow cells cultured 
in the presence of high-dose I1:2 (activated bone marrow cells 
[ABM]) mediate strong veto suppressor function in vitro and 
in vivo (15). Such cell populations do not express appreciable 
levels of CD4 or CD8 (15). To determine whether CD4- / 
CD8- ABM suppress p-CTL responses by clonal anergy or 
deletion mechanisms, we examined CTL responses in MLCs 
in which the responding cells were from transgenic mice ex- 
pressing at high frequency TCR specific  for H-2 L  a (16, 17). 
1 Abbreviations used in this  paper: ABM, activated bone marrow cells; CML, 
cell-mediated lysis; FCM, flow cytometry; lyCTL, precursor cytotoxic T 
lymphocytes; PI, propidium iodide. 
Our experiments demonstrated that the anti-H-2  d cytotoxic 
response by these cell populations was specifically  suppressed 
by H-2  d ABM, and that p-CTL were in fact deleted from 
the responding cell population by veto cells expressing the 
target antigen. These data indicate that ABM veto cells kill 
p-CTL with specificity for antigens expressed on the surface 
of the ABM, and that the mechanism for veto cell activity 
of ABM is clonal deletion of postthymic p-CTL, rather than 
induction of anergy. 
Materials and Methods 
Mice.  C57BL/6, (B6, H-2b), DBA/2 (H-2d), C3H/HeJ (C3H, 
H-2k), B10.BR (H-2k), (C57BL/6  x  C3H/He)F1 (B6C3F1, 
H-2b/k), (C3H/HeJ x DBA/2)F1 (C3D2F1, H-2k/d), and (B10.BR 
x B10.D2)F1 (BRD2F1, H-2  k/d) were  obtained from  The Jackson 
Laboratory (Bar Harbor, ME) or were bred at National Cancer 
Institute-Frederick  Cancer Research  Center (Frederick,  MD). The 
Dd/L  d mutant mice, dml, were kindly provided by Dr. Jay Ber- 
zofsky  (National Institutes of Health, Bethesda, MD). Transgenic 
H-2  b mice expressing the c~/~ T cell receptor from the cytotoxic 
T cell (CTL) clone  2C (16, 17) were  kindly  provided  by Dr. Dennis 
Y. Loh (Washington  University  School  of  Medicine,  St. Louis, MO). 
ABM.  The methods of generation of ABM were previously 
described (15). Briefly,  bone marrow cells were depleted  of T ceils 
by two rounds  of  treatment  with mixture  of  anti-T ceU mAbs  (HO- 
13-4, 83-12-5, and C3PO) and guinea pig complement (Gibco 
Laboratories, Grand Island, NY). These T  cell-depleted bone 
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10% FCS, sodium pyruvate,  nonessential  amino acids, r-glutamine, 
2-ME, penicillin, and streptomycin)  containing 1,000 U/ml human 
rlL-2 (generously supplied by Cetus Corp., Emeryville, CA) for 
4-10 d at 370C in a humidified chamber containing 5% CO2. 
These cells were washed twice with media before further  ex- 
periments. 
MLC.  MLC was set up using 4  x  106 spleen cells from the 
indicated mice as responder cells and 2  x  106 spleen cells from 
the indicated mice irradiated with 2,500 cGy as stimulator cells 
in 2 ml of complete media in a 24-well culture plate (Costar Data 
Packaging Corp., Cambridge, MA). To evaluate the veto suppres- 
sive activity of ABM cells, these cells were added to the MLC on 
day 2. After culture for 5 d, effector  cells were harvested and tested 
for specific cytotoxicity. 
Cell.mediated  Lysis (CML) Assay.  Allospecific  cytotoxic activity 
of MLC was assessed by CML assay, as previously described (15). 
Target cells were prepared by culturing spleen cells for 2 d in the 
presence of 3/~g/ml Con A and labeling with Na[SlCr]O4 (Amer- 
sham Corp., Arlington Heights, IL). CML assay was performed 
using variable numbers of effector MLC cells and 5  x  103 target 
cells in 96-well U-bottomed plates. S*Cr release was measured after 
a 4-h incubation at 37°C. Results are expressed as a specific lysis 
calculated as follows: percent specific  lysis =  100x [(experimental 
release -  spontaneous release)/(maximum release -  spontaneous 
release)]. 
NK cell activity of ABM was assessed similarly by CML assay 
in which ABM were used as effector cells and YAC-1 cells were 
used as target cells in a 4-h SlCr-release assay. In addition, killing 
activity of ABM against the transgenic H-2  b mice anti-BRD2F1 
MLC was also assessed  by CML assay  using DBA/2 ABM and C3H 
ABM as effector cells, and MLC cells as target cells. 
Antigranule Antibody.  Antigranule antibody was prepared by 
producing rabbit antiserum against highly purified preparations of 
cytoplasmic granules from a rat large granular lymphocyte tumor 
line, as previously  described (18). To evaluate  the effect  of antigranule 
antibody on veto mechanism, antigranule antibody (final concen- 
tration 1:200) was added to the MLC on day 2 of culture at the 
time of addition of ABM. Anti-KLH antibody was used as a con- 
trol antibody. 
Evaluation of Cell Death by Flow  Cytometry  (FCM) with  Propidium 
Iodide (PI)-stained  Cells.  MLC was set up using 0.4  x  106 trans- 
genic H-2  b mice spleen cells/well mixed with 3.6  x  106 normal 
B6  spleen cells/well  as  responder cells. 2,500 cGy-irradiated 
C3D2Fx spleen cells were used as stimulator cells. Cells were col- 
lected from the MLC on day 2, cleared  of  dead  cells  by centrifugation 
over lymphocyte separation media (Organon Technika, Durham, 
NC), and put back in culture. A portion of cells after the separa- 
tion were used for flow cytometric analysis  before further manipu- 
lation of cultures, then 106 ABM/well were added to the culture 
as indicated. The cells were collected from the MLC 24 h after 
addition of ABM, washed, and incubated with 1B2 for 30 min 
at 4oC, followed  by FITC-conjugated goat anti-mouse Ig (gamma 
specific; Fisher Scientific Co., Pittsburgh,  PA). After addition of 
0.8 mg/ml of PI (Fluka Chemical Corp., Ronkonkoma, NY) as 
an indicator of  dead cells (19), cells  were analyzed  using FACScan  ® 
(Becton Dickinson & Co., Mountain View, CA). Fluorescence  data 
were collected using a logarithmic amplification on 20,000 cells 
after gating out cell fragments or debris smaller than dead cells 
stained with PI by forward light scatter intensity. These small frag- 
ments were distinguished clearly from PI-stained dead cells. Two- 
color immunofluorescence  data were displayed  as contour diagrams 
in which log intensities of green (FITC) and red (PI) fluorescences 
were plotted on the x-axis and y-axis, respectively.  Lines used to 
define positive and negative cells were set against the outermost 
contour  of staining controls  in  which  FITC-conjugated goat 
anti-mouse Ig alone was used. Positive percentage shown in the 
boxes are values from which background (control staining) values 
have been subtracted (see Fig. 4 A). Absolute cell numbers of each 
cell population were calculated using the positive percentages by 
FCM analysis  and live cell number/well of the culture assessed  by 
trypan blue exclusion. 
Results and Discussion 
Veto Cell Activity of  ABM.  Recent evidence suggests that 
suppression  of CTL responses by veto cells may play an im- 
portant role not only in the maintenance of self-tolerance, 
but also in the negative regulation of ongoing immune re- 
sponses (11-15, 20-22). Most evidence has favored induction 
of anergy of p-CTL as the mechanism by which veto cells 
suppress  T  cell cytotoxic responses  (21). Major difficulties 
in investigating mechanisms of veto cell function have been 
the unreliable suppressor activity of veto cell populations and 
the low precursor frequency of responding p-CTL suscep- 
tible  to  veto  suppression  during  a  primary  response.  As 
reported previously (15), we and others (23) have overcome 
the problem of poor reliability of veto cell function by in- 
cubating bone marrow cells, which have been reported to 
contain veto cells (24), with II,-2. To assess the veto activity 
of such  ABM,  C57BL/6  (B6,  H-2  b)  ABM  or  C3H/He 
(C3H,  H-2  k)  ABM  were  added  to  DBA/2  (H-2  d)  anti- 
(C57/BL6  x  C3H/He)F1  (B6C3F1,  H-2  b/k)  MLC.  As 
shown in Fig.  1 A, the addition of B6 ABM significantly 
suppressed the generation of an anti-H-2  b cytotoxic response 
as compared with the response  with added C3H ABM or 
no  added  ABM.  Conversely,  the  generation  of an  anti- 
H-2  k cytotoxic response  of the same MLC was significantly 
suppressed  by addition of C3H ABM, but not by addition 
of B6 ABM or no ABM (Fig.  1 B).  The use of F1 stimu- 
lator cell populations excluded as a mechanism of suppres- 
sion the possibility that veto activity was mediated by elimi- 
nation of the stimulator cell population by ABM. Further 
studies demonstrated that the MLC responder population was 
susceptible to veto cell suppression from 1-3 d of culture with 
maximal veto cell suppression  observed when veto cells were 
added 2 d after initiating the MLC (data not shown). There- 
fore, ABM-mediated suppression  of cytotoxic responses was 
characteristic  of veto cell populations in that the suppressive 
activity was antigen specific and acted upon cytotoxic cells 
soon after primary stimulation. The possibility that suppres- 
sion of target cell lysis in the chromium release assay was 
due to cold target inhibition associated with the presence of 
target antigen-expressing veto cells in the effector popula- 
tion, was eliminated by treating the effector cells with ap- 
propriate antibody and complement (15). Additional studies 
demonstrated that the ABM cell population, after 7-10 d of 
culture with added Ib2, was relatively homogeneous and ex- 
pressed Thy-1 and NKI.1, but not MAC-l, CD4, CD8, or 
CD3. ABM cells had substantial levels of both NK cell and 
LAK cell activity (data  not shown). 
Antigranule Antibody Inhibits Veto Cell Activity.  If clonal 
deletion of p-CTL is the mechanism by which veto cells sup- 
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Figure 1.  Activated bone marrow (ABM) cells suppress cytotoxic re- 
sponses directed against MHC antigen expressed on their cell surface. An 
anti-C57BL/6 (B6,  H-2  b)  cytotoxic  response  of DBA/2  (H-2  a)  anti- 
(C57BL/6  x  C3H/He)F1 (B6C3F, H-2  b/k) MLC was suppressed by ad- 
dition of B6 ABM, but not C3H/He (C3H, H-2  k) ABM (A). An anti- 
C3H cytotoxic response of the same MLC was suppressed by addition of 
C3H ABM, but not by B6 ABM (B). 
press the generation of cytotoxic responses, then lysis of p-CTL 
most likely is involved. Such lysis would presumably proceed 
via degranulation of either the veto cell population or per- 
haps the p-CTL (cellular "suicide"). To assess the possibility 
that a granule-mediated lytic event was involved in veto cell 
suppression of a CTL response, the effect of neutralizing an- 
tigranule antibody (18) on veto activity was investigated.  Such 
antigranule antibody preparations have previously been demon- 
strated to inhibit lysis by NK effector cells (18, 25). As shown 
in Fig. 2 A, antigranule antiserum, but not a control anti- 
KLH antiserum, inhibited B6 ABM-mediated suppression 
of an anti-H-2  b cytotoxic response in a DBA/2 (H-2  a) anti- 
B6 (H-2  b) MLC and resulted in near complete restoration 
of CTL activity compared with control values (addition of 
antigranule antiserum alone). When C3H ABM were added 
to the same MLC to confirm the specificity of veto activity, 
no suppression of anti-H-2  b cytotoxic response was observed 
(Fig. 2 B). Preincubation of either the responder population 
or the ABM population with chloroquine, an inhibitor of 
lytic granule activity (26), demonstrated that the granule ac- 
tivity contributing to veto cell-mediated suppression resided 
in the ABM but not in the p-CTL population, and thereby 
indicated that a cellular suicide mediated by granules of p-CTL 
was unlikely (data not shown). These experiments strongly 
suggested that veto cell-mediated suppression of CTL re- 
sponses required veto cell degranulation and that a lytic event 
was therefore critical to such suppression.  These results would 
be consistent with previously reported observations correlating 
veto activity of cell populations with cytotoxic potential (12). 
ABM Can Lyse MLC Responder Cells.  To directly assess 
the possibility of clonal deletion of p-CTL by veto cells, it 
was necessary to circumvent the problem of inherently low 
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Figure 2.  Antigranule  antibody, but not a control anti-KLH antibody, 
inhibits B6 ABM-mediated suppression of an anti-H-2  b cytotoxic re- 
sponse in DBA/2 anti-B6 MI~. Addition of antigranule antibody alone 
suppressed slightly the cytotoxic activity in the same MLC (A). Anti- 
H-2  b cytotoxic activity in the same MLC was not suppressed by addition 
of C3H ABM (B). 
p-CTL frequency in the responder cell population of a MLC. 
To do this, we used as responder cells spleen cells of trans- 
genic H-2  b mice expressing the or~3 TCR from the CTL 
clone 2C (16, 17) as a source ofp-CTL. This TCR is specific 
for  the  class  I  MHC-encoded  antigen  L a  and  can  be 
specifically identified by the mAb 1B2 (16). To test whether 
the anti-H-2 a response of the CTL from the transgenic mice 
could  be  suppressed  by  ABM,  DBA/2  (H-2  a)  ABM, 
B10.BR (H-2  k) ABM, or dml (a H-2L  a and D a mutant of 
B10.D2), ABM were added to a MLC in which the responder 
cells were derived from the spleen of a transgenic mouse (H- 
2  b)  and  the  stimulator  cells  were  H-2  a/k  (BRD2F1).  As 
shown in Fig. 3 A, the addition of DBA/2 ABM significantly 
suppressed the generation of an anti-H-2  a cytotoxic response 
of the MLC  as  compared with  the response with  added 
B10.BR ABM, dml ABM, or no ABM.  The assay of NK 
cell activity demonstrated comparable cytolytic activity of 
the various ABM populations (Fig.  3 B). Thus, an anti-H- 
2  a cytotoxic response generated from the transgenic H-2  b 
mice can be significantly suppressed by H-2  a ABM, but not 
by H-2  k ABM or Da/L a mutant ABM. Therefore, ABM can 
exert a veto-suppressive action on the anti-H-2 a CTL re- 
sponse generated by these transgenic responder cell popu- 
lations. 
Although it has been determined by functional assays that 
veto cells decrease the frequency of p-CTL that respond to 
stimulator cells in MLC (13, 14), it has been unclear whether 
veto cells kill p-CTL (resulting in clonal deletion), or induce 
antigen unresponsiveness (anergy) of this cell population, 
thereby rendering it incapable of differentiating into func- 
tional CTL. To assess the mechanism of veto cell suppression 
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Figure 3.  The anti-H-2 d cytotoxic 
response of the transgenic H-2  b mice 
anti-(B10.BR x B10.D2)F1  (BRD2F1, 
H-2  k/d) MLC is suppressed by DBA/2 
ABM but not by B10.BR (H-2  k) or 
din1 (H-2 D  b, L  d mutant) ABM (A) 
although each ABM population pos- 
sessed comparable  NK cell activity (B). 
Cells of the same MLC on day 2 of cul- 
ture were lysed by DBA/2 ABM, but 
not by C3H ABM or dml ABM (C). 
of CTL responses,  we first directly evaluated p-CTL lysis by 
ABM using a 51Cr-release assay. The transgenic H-2  b mouse 
spleen cells were stimulated with irradiated BRD2F1 spleen 
cells for 2 d and then used as target cells. As shown in Fig. 
3  C,  the responder cells from the TCR transgenic mouse 
anti-BRD2F1 MLC were lysed by DBA/2 ABM, but not by 
B10.BR ABM or dml ABM, but the present specific cell lysis 
of the MLC was relatively low (14.9% at E/T ratio 100:1). 
These data suggested that ABM could kill MLC responder 
cells, but it remained unclear whether the degree of killing 
observed could account for a full suppression of the CTL 
response or whether the cells killed were in fact p-CTL. The 
use of purified T  cell responder populations as target cells 
and of longer periods of incubation during the 51Cr-release 
assay failed to resolve these issues. 
ABM Veto Cells Mediate Clonal Deletion of p-CTL.  Be- 
cause more than 95% of CD8-positive cells derived from these 
transgenic  mice were  1B2  positive  and  no  anti-H-2 k re- 
sponse was generated from the TCR transgenic H-2  b mouse 
anti-BRD2F1 MLC (data not shown), the specificity of veto 
activity of DBA/2 ABM versus a third-party ABM popula- 
tion (e.g., H-2 k) could not be defined. Therefore, we used 
as responder populations in MLC a mixture of spleen cells 
from  transgenic  and  normal B6  (H-2  b)  mice and  H-2 d/k 
stimulator  cells  to  generate  simultaneous  anti-H-2 d and 
anti-H-2 k cytolytic responses  in MLC to evaluate specificity 
of activity of the various ABM populations in the same MLC. 
The initial responder cell population was made up of 10% 
transgenic mouse spleen cells and 90% normal B6 spleen cells, 
and veto cell activity of H-2  d ABM and H-2 k ABM was as- 
sessed. The addition of DBA/2 ABM markedly suppressed 
the generation of an anti-H-2 d response, as compared with 
the response with added C3H ABM or no added ABM. An 
anti-H-2 k response,  generated from the  same MLC,  was 
suppressed by addition of C3H, but not DBA/2, ABM (data 
not shown). To examine whether responder p-CTL could 
be killed by ABM, we performed flow cytometric analysis 
of responder cell populations  derived from the transgenic 
mouse using the mAb 1B2 specific for the transgene-encoded 
TCR, and determined changes of the T cell population ex- 
pressing this receptor in the MLC after addition of ABM. 
In addition, we studied the cell population by staining with 
PI (19) as an indicator of dead cells. At 48 h  of MLC and 
before addition of ABM, the responder population had 3.9% 
1B2-positive, live cells and had 11.1% dead (PI-positive)  cells. 
After another 24 h of culture with no ABM, the percentage 
of l_B2-positive live cells increased approximately fourfold with 
a more modest increase of dead cells (Fig. 4 A). In those MLCs 
to which DBA/2 ABM were added, live 1B2-expressing  T 
cells were dramatically decreased to virtually undetectable levels 
(0.2%),  accompanied by a substantial increase in dead cells 
as compared with control cultures. Addition of C3H ABM 
did not reduce the 1B2-positive cell population. In addition, 
the absolute cell number of 1B2-positive cells was also markedly 
reduced, and the dead cell number increased after addition 
of DBA/2 ABM, but not after addition of C3H ABM (Fig. 
4 B). Because the cell number of 1B2-negative cells was not 
reduced by addition of DBA/2 ABM and the 1B2-positive 
cell population virtually disappeared, the increment of dead 
cells in the MLC in the presence of DBA/2 ABM was likely 
due to the death of 1B2-positive  cells. Downregulation of 
TCR expression, rather than death of the p-CTL popula- 
tion, was ruled out by staining with anti-CD3  and -CD8 
mAbs that  demonstrated an  absence of any new CD8+/ 
CD3-  population after exposure of the MLC population to 
veto cells. Because antibody nonspecifically associates with 
dead cells, no attempt to interpret the 1B2 staining of PI- 
positive cells was made in the experiments shown in Fig. 4. 
These data  demonstrate that  H-2  d,  but  not  H-2 k,  ABM 
eliminate live 1B2-positive  (but not 1B2-) cells from the re- 
sponding population.  Thus, p-CTL are clonally deleted by 
ABM in an antigen-specific manner. This appears mechanisti- 
cally distinct from effects mediated through CD8 as an in- 
hibitory ligand (27), in that the veto cells in the population 
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Figure 4.  1B2 positive cells are elim- 
inated  and Pl-stained  cells increase in 
the transgenic H-2  b mice anti-(C3H  x 
DBA/2)F1  (C3D2Fh  H-2  d/k)  MLC 
24-h  after  addition of DBA/2 ABM 
(H-2d), but not after addition of C3H 
(H-2  k)  ABM  (A).  It  was  confirmed 
that  absolute  cell  number  of  1B2- 
positive cells in the MLC was dramati- 
caUy reduced  by addition of DBA/2 
ABM (B). 
used in these experiments do not express  CD8 by fluores- 
cence analysis (15), and also distinct from cell death induced 
by signaling through the TCR and class I MHC molecules 
that can be mediated by antibodies of the appropriate specificity 
in the absence of a cytotoxic veto cell population  (22). 
If the mechanism of veto cell-mediated suppression of CTL 
responses involves  degranulation of veto cells and lysis and 
deletion of p-CTL, as indicated in these experiments, the ques- 
tion of how that degranulation is triggered must be consid- 
ered. This consideration must take into account the observa- 
tion that p-CTL,  but not mature CTL,  are susceptible to 
veto suppression, and that veto cell populations can mediate 
specific suppression of cytotoxic T cell responses even to ac- 
quired antigens on the surface of veto cells (11). One possi- 
bility we would propose is that the developing p-CTL ac- 
quires the capacity to deliver an excitatory signal to the veto 
cell after TCR-mediated recognition of antigen expressed on 
the surface of the veto cell. Specifically, the veto cell stimulus 
would result from p-CTL degranulation of immature granules 
containing limited cytolysin capable of mediating some ion 
(especially calcium) leakage with subsequent membrane re- 
pair by the veto cell. This ion leakage would stimulate veto 
cell degranulation resulting in lysis of the p-CTL, and so would 
be similar to "backwards" killing of cells bound to triggered 
cytotoxic lymphocytes (28). 
Whatever the events might be that mediate triggering of 
ABM, the findings presented here provide clear evidence that 
this veto cell population mediates suppression of CTL re- 
sponses by clonal deletion of p-CTL. Preliminary results of 
recent experiments  suggest  that  veto  cell  populations  in 
marrow not exposed to exogenous ILo2 in vitro similarly act 
by clonal deletion of p-CTL. These results, in combination 
with previous work showing antigen-specific effects of veto 
cell populations in vivo (15), suggest that clonal deletion of 
postthymic T  cells by veto cells represents a mechanism of 
tolerance that is operative among unmanipulated cell popu- 
lations in vivo. 
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